三、分红送配方案情况 本次公司不分配不转赠。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0000 | -0.0068 | 100 | -0.0700 | | 每股净资产（元） | 0.25 | 0.05 | 400 | 1.24 | | 每股公积金(元) | 1.61 | 1.56 | 3.21 | 1.56 | | 每股未分配利润(元) | -2.40 | -2.55 | 5.88 | -1.39 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.62 | 0.71 | -12.68 | 0.84 | | 净利润(亿元) | -0.02 | -0.04 | 50 | -0.32 | | 净资产收益率(%) | -1.84 | -6.12 | 69.93 | -4.47 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 2 ...

Financial Performance - The company reported a basic earnings per share of 0.6700 yuan for 2024, a significant increase of 115.91% compared to a loss of 4.2100 yuan in 2023 [1] - The net profit for 2024 was 5.79 billion yuan, recovering from a loss of 36.51 billion yuan in 2023, marking a 115.86% improvement [1] - Operating revenue decreased to 87.63 billion yuan in 2024, down 54.96% from 194.58 billion yuan in 2023 [1] - The net asset return rate was not reported for 2024, but it was -49.79% in 2022 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 91,766.53 million shares, accounting for 62.52% of the circulating shares, with an increase of 60,495.80 million shares compared to the previous period [1] - New significant shareholders include Fujian Aonong Biotechnology Group Co., Ltd. with 47,941.08 million shares (32.66% of total shares) and Xinyang Bank with 8,665.81 million shares (5.90% of total shares) [2] - Notable exits from the top ten shareholders include Huang Zuyiao and Cen Yetao, who have withdrawn from the list [2] Dividend Distribution - The company has announced no distribution or capital increase for the current period [3]

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0223 | 0.0034 | 555.88 | 0.0916 | | 每股净资产（元） | 0 | 2.08 | -100 | 3.16 | | 每股公积金(元) | 1.2 | 0 | 0 | 1.19 | | 每股未分配利润(元) | 0.92 | 0.69 | 33.33 | 0.31 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.66 | 1.22 | -45.9 | 1.3 | | 净利润(亿元) | 0.11 | 0.02 | 450 | 0.44 | | 净资产收益率(%) | | 0.11 | -100 | 2.95 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 29433.78万股，累计占流通股比： 60.7%，较上期变化： 125.42万股。 本次公司 ...

Financial Performance - The company reported a basic earnings per share of -0.0089 yuan for Q1 2025, an improvement of 22.61% compared to -0.0115 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.18 billion yuan, showing a 21.74% increase from -0.23 billion yuan in Q1 2024 [1] - Operating revenue increased by 8.46% to 1.41 billion yuan in Q1 2025, compared to 1.3 billion yuan in Q1 2024 [1] - The return on equity was -1.02% in Q1 2025, slightly worse than -0.94% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 83,827.98 million shares, accounting for 50.22% of the circulating shares, with a decrease of 17.45 million shares from the previous period [1] - Shenzhen Landi Technology Development Co., Ltd. remains the largest shareholder with 21,877.26 million shares, representing 13.11% of total share capital [2] - New entrant in the top ten shareholders is Li Songqiang, holding 1,543.61 million shares, which is 0.92% of total share capital [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]

Financial Performance - The company reported a basic earnings per share of 0.2700 yuan for Q1 2025, representing a 12.5% increase compared to 0.2400 yuan in Q1 2024 and a significant rise from 0.1400 yuan in Q1 2023 [1] - The total revenue for Q1 2025 was 8.56 billion yuan, up 9.46% from 7.82 billion yuan in Q1 2024 and an increase from 6.65 billion yuan in Q1 2023 [1] - The net profit for Q1 2025 was 1.6 billion yuan, reflecting an 11.11% increase from 1.44 billion yuan in Q1 2024 and a rise from 0.83 billion yuan in Q1 2023 [1] - The return on equity (ROE) for Q1 2025 was 4.66%, up from 4.21% in Q1 2024 and significantly higher than 2.69% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 43,969.54 million shares, accounting for 73.81% of the circulating shares, with a decrease of 354.64 million shares compared to the previous period [1] - RED AVENUE INVESTMENT GROUP LIMITED remains the largest shareholder with 29,457.00 million shares, representing 49.45% of the total share capital, unchanged from the previous period [2] - Virgin Holdings Limited holds 8,016.27 million shares, accounting for 13.46%, also unchanged [2] - The shareholding of Zhoushan Yutong Venture Capital Partnership decreased by 144.47 million shares to 2,994.99 million shares, representing 5.03% [2] - The company has not declared any dividend distribution or transfer for this period [2]

Financial Performance - The company reported a basic earnings per share of -0.0900 yuan for Q1 2025, an improvement of 10% compared to -0.1000 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.27 billion yuan, showing a 10% improvement from -0.30 billion yuan in Q1 2024 [1] - The operating revenue decreased by 10.78% to 0.91 billion yuan in Q1 2025, down from 1.02 billion yuan in Q1 2024 [1] - The return on equity was -66.12% in Q1 2025, a significant decline from -16.29% in Q1 2024 [1] - The net asset per share dropped by 83.64% to 0.09 yuan in Q1 2025, compared to 0.55 yuan in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 14,786.49 million shares, accounting for 46.21% of the circulating shares, with an increase of 3.33 million shares from the previous period [1] - Shandong Haike Holdings Co., Ltd. remains the largest shareholder with 7,785.31 million shares, representing 24.33% of the total share capital [2] - New entrants among the top shareholders include Zhang Tao with 514.76 million shares (1.61%) and Fu Yong with 155.00 million shares (0.48%) [2] - UBS AG, Liu Shaolin, and Zou Jun have exited the top ten shareholders list [2] Dividend Policy - The company has announced that it will not distribute dividends or allocate bonus shares this time [3]

Financial Performance - The basic earnings per share decreased by 28.09% from 0.1794 yuan in 2023 to 0.1290 yuan in 2024 [1] - Operating revenue fell by 10.33% from 6.68 billion yuan in 2023 to 5.99 billion yuan in 2024 [1] - Net profit decreased by 28.03% from 1.32 billion yuan in 2023 to 0.95 billion yuan in 2024 [1] - Return on equity dropped from 5.55% in 2023 to 4.00% in 2024, a decline of 27.93% [1] - The net asset per share increased slightly by 2.52% from 3.17 yuan in 2023 to 3.25 yuan in 2024 [1] - The undistributed profits per share increased by 13.46% from 0.52 yuan in 2023 to 0.59 yuan in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 15,443,240 shares, accounting for 26.57% of the circulating shares, with a change of 1,953,700 shares from the previous period [1] - Wang Jinghua remains the largest shareholder with 5,094.02 million shares, representing 8.76% of the total share capital [2] - Yan Xianghong exited the top ten shareholders, having previously held 2,000 million shares [2] - New entrants to the top ten shareholders include Yin Jun with 764.01 million shares and Zhang Lekun with 330.27 million shares [2] Dividend Distribution - The company announced a dividend distribution of 1.77 yuan per share (including tax) [3]

Financial Performance - The company's basic earnings per share decreased by 39.19% from 0.7400 yuan in 2023 to 0.4500 yuan in 2024 [1] - Operating revenue increased by 19.28%, rising from 11.36 billion yuan in 2023 to 13.55 billion yuan in 2024 [1] - Net profit fell by 24.24%, from 1.32 billion yuan in 2023 to 1 billion yuan in 2024 [1] - Return on equity decreased significantly by 56.39%, from 10.64% in 2023 to 4.64% in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 2,016.13 million shares, accounting for 28.5% of the circulating shares, with an increase of 12,637.6 million shares compared to the previous period [1] - New significant shareholders include Luoyang Xinqianglian and Ningbo Lanxi Innovation Equity Investment Partnership, each holding 740.00 million shares (10.46%) and 370.00 million shares (5.23%) respectively [2] - Several previous top shareholders have exited, including Li Xiaoguang and Goldman Sachs, indicating a shift in shareholder composition [2] Dividend Distribution - The company announced a dividend distribution plan of 0.50 yuan per share (including tax) [3]

Financial Performance - The company reported a basic earnings per share of 0.2816 yuan for Q1 2025, representing a 30.19% increase compared to 0.2163 yuan in Q1 2024 [1] - Revenue for the period reached 2.15 billion yuan, up 22.16% from 1.76 billion yuan in the same quarter last year [1] - Net profit increased by 30.77% to 0.17 billion yuan from 0.13 billion yuan year-on-year [1] - The return on equity was recorded at 1.82% [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 1.1517 million shares, accounting for 5.75% of the circulating shares, with no change from the previous period [1] - New significant shareholders include entities such as Wan Changcheng with 0.2138 million shares (1.07% of total shares) and Morgan Stanley & Co. International PLC with 0.2019 million shares (1.01% of total shares) [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in the current period [3]

Financial Performance - The company's basic earnings per share decreased by 50% to 0.0300 yuan in Q1 2025 compared to Q1 2024, which was 0.0600 yuan [1] - Net profit for Q1 2025 was 0.02 billion yuan, down 50% from 0.04 billion yuan in Q1 2024 [1] - Operating revenue fell by 9.3% to 0.78 billion yuan in Q1 2025 from 0.86 billion yuan in Q1 2024 [1] - The return on equity (ROE) dropped significantly by 57.45% to 0.20% in Q1 2025 from 0.47% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 46.4623 million shares, accounting for 73.68% of the circulating shares, with a decrease of 556,100 shares compared to the previous period [1] - Beijing Huiguang Runkang Pharmaceutical Development Co., Ltd. remains the largest shareholder with 18.6709 million shares, representing 29.61% of total share capital [2] - New entrants among the top shareholders include Shuangrun Zheng'an Information Consulting (Beijing) Co., Ltd. with 14.3262 million shares, accounting for 22.72% [2] Dividend Policy - The company has announced that it will not distribute dividends or allocate shares this time [3]